BioCentury
ARTICLE | Company News

XenoPort, Arbor Pharmaceuticals deal

May 30, 2016 7:00 AM UTC

Specialty pharma Arbor will acquire XenoPort for $7.03 per share in a cash deal the companies say values XenoPort at $467 million. The price is a 60% premium to XenoPort’s close of $4.40 on May 20, th...